Current Challenge: Macrophage Activation Syndrome
Macrophage activation syndrome (MAS) is a severe, potentially life-threatening condition involving a massive inflammatory response that overwhelms the whole body.
Two pooled open-label studies with a new investigational drug aimed to reduce the dose of the current harmful standard therapy (GC).
The challenge is to visualise:
- How effective was the new investigational drug in reducing GC doses over 8 weeks?
- What proportion of subjects achieved GC doses between certain thresholds, and how did this change over time?
- How much variability was there in GC doses, e.g. characterise shifts between threshold levels at the individual subject level?
* NOTE to download a single data set as a csv file, click on the raw button and save the file. The following link describes the process in further detail